Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/31/2024 | MRK | Buy Now | Merck & Co | $112.88 | 25.8% | $148 → $142 | Maintains | Buy | Get Alert |
07/31/2024 | PFE | Buy Now | Pfizer | $30.80 | 0.67% | $30 → $31 | Maintains | Neutral | Get Alert |
05/03/2024 | AMGN | Buy Now | Amgen | $334.82 | -8.31% | $284 → $307 | Maintains | Neutral | Get Alert |
04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.09K | 1.09% | $1090 → $1099 | Maintains | Buy | Get Alert |
04/17/2024 | AMGN | Buy Now | Amgen | $334.82 | -15.18% | $314 → $284 | Maintains | Neutral | Get Alert |
04/17/2024 | BIIB | Buy Now | Biogen | $217.72 | -1.71% | $250 → $214 | Maintains | Neutral | Get Alert |
04/17/2024 | GILD | Buy Now | Gilead Sciences | $76.92 | -2.5% | $81 → $75 | Maintains | Neutral | Get Alert |
04/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -6.9% | $498 → $466 | Maintains | Buy | Get Alert |
03/28/2024 | ENGN | Buy Now | enGene Holdings | $10.00 | 270% | → $37 | Initiates | → Buy | Get Alert |
03/01/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $24.68 | 118.8% | $56 → $54 | Maintains | Buy | Get Alert |
03/01/2024 | SRPT | Buy Now | Sarepta Therapeutics | $143.31 | 16.53% | $164 → $167 | Maintains | Buy | Get Alert |
02/21/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 253.98% | $9 → $4 | Downgrade | Buy → Neutral | Get Alert |
02/16/2024 | BIIB | Buy Now | Biogen | $217.72 | 14.83% | $276 → $250 | Maintains | Neutral | Get Alert |
02/02/2024 | MRK | Buy Now | Merck & Co | $112.88 | 31.11% | $135 → $148 | Maintains | Buy | Get Alert |
01/29/2024 | AMGN | Buy Now | Amgen | $334.82 | -6.22% | $315 → $314 | Maintains | Neutral | Get Alert |
01/25/2024 | BIIB | Buy Now | Biogen | $217.72 | 26.77% | $311 → $276 | Downgrade | Buy → Neutral | Get Alert |
01/24/2024 | BIIB | Buy Now | Biogen | $217.72 | 26.77% | → $276 | Downgrade | Buy → Neutral | Get Alert |
12/14/2023 | PFE | Buy Now | Pfizer | $30.80 | -12.32% | $34 → $27 | Maintains | Neutral | Get Alert |
12/01/2023 | IMVT | Buy Now | Immunovant | $28.20 | 98.58% | $55 → $56 | Maintains | Buy | Get Alert |
11/02/2023 | AMGN | Buy Now | Amgen | $334.82 | -19.96% | $272 → $268 | Maintains | Neutral | Get Alert |
10/20/2023 | PFE | Buy Now | Pfizer | $30.80 | 10.41% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert |
10/13/2023 | IMVT | Buy Now | Immunovant | $28.20 | 95.04% | $18 → $55 | Upgrade | Neutral → Buy | Get Alert |
10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $4.96 | 444.35% | $29 → $27 | Maintains | Buy | Get Alert |
07/24/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -15.29% | $399 → $424 | Maintains | Buy | Get Alert |
07/21/2023 | CCC | Buy Now | Carlyle Commodities | — | — | $22 → $20 | Maintains | Buy | Get Alert |
05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $143.31 | 20.72% | $160 → $173 | Maintains | Buy | Get Alert |
05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -20.29% | $375 → $399 | Maintains | Buy | Get Alert |
03/15/2023 | ALXO | Buy Now | ALX Oncology Holdings | $4.96 | 484.68% | $31 → $29 | Maintains | Buy | Get Alert |
02/16/2023 | BIIB | Buy Now | Biogen | $217.72 | 56.17% | $337 → $340 | Maintains | Buy | Get Alert |
02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -25.08% | $373 → $375 | Maintains | Buy | Get Alert |
01/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -25.48% | $342 → $373 | Maintains | Buy | Get Alert |
01/26/2023 | PFE | Buy Now | Pfizer | $30.80 | 52.62% | $55 → $47 | Downgrade | Buy → Neutral | Get Alert |
12/16/2022 | SRPT | Buy Now | Sarepta Therapeutics | $143.31 | 10.25% | $100 → $158 | Upgrade | Neutral → Buy | Get Alert |
12/15/2022 | LLY | Buy Now | Eli Lilly | $798.84 | -47.42% | $428 → $420 | Maintains | Buy | Get Alert |
12/08/2022 | OMER | Buy Now | Omeros | $5.51 | -63.7% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
10/21/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -32.67% | $335 → $337 | Maintains | Buy | Get Alert |
10/18/2022 | PROK | Buy Now | ProKidney | $2.38 | 656.3% | → $18 | Initiates | → Buy | Get Alert |
10/06/2022 | BIIB | Buy Now | Biogen | $217.72 | 41.93% | $238 → $309 | Maintains | Buy | Get Alert |
09/27/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $24.68 | 151.22% | $68 → $62 | Maintains | Buy | Get Alert |
09/26/2022 | IMVT | Buy Now | Immunovant | $28.20 | -82.27% | $7 → $5 | Downgrade | Buy → Neutral | Get Alert |
08/01/2022 | ABBV | Buy Now | AbbVie | $184.88 | -21.03% | $154 → $146 | Maintains | Neutral | Get Alert |
07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $47.98 | 56.33% | $73 → $75 | Maintains | Neutral | Get Alert |
07/18/2022 | MRK | Buy Now | Merck & Co | $112.88 | -13.18% | $76 → $98 | Maintains | Neutral | Get Alert |
04/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -35.67% | $325 → $322 | Maintains | Buy | Get Alert |
04/18/2022 | CCCC | Buy Now | C4 Therapeutics | $6.43 | 304.35% | $64 → $26 | Maintains | Buy | Get Alert |
04/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -35.07% | $258 → $325 | Maintains | Buy | Get Alert |
02/28/2022 | ABBV | Buy Now | AbbVie | $184.88 | -20.49% | $129 → $147 | Downgrade | Buy → Neutral | Get Alert |
02/16/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 2112.39% | $88 → $25 | Maintains | Buy | Get Alert |
12/13/2021 | MRK | Buy Now | Merck & Co | $112.88 | -32.67% | — | Downgrade | Buy → Neutral | Get Alert |
12/13/2021 | PFE | Buy Now | Pfizer | $30.80 | 94.84% | — | Upgrade | Neutral → Buy | Get Alert |
05/12/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -44.26% | $278 → $279 | Maintains | Buy | Get Alert |
11/20/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $500.54 | -42.46% | $287 → $288 | Maintains | Buy | Get Alert |